← Eichor · All briefs
DealScout
$499/mo · cancel anytime · transparent pricing, no sales call
Identify potential partnering opportunities before they
become obvious in company updates. Every week, Eichor identifies companies with
clinical programs showing public-record indicators such as enrollment slowdowns, site
reductions, timeline drift, or registry inactivity. Every signal is scored, explained in
plain language, and linked to the underlying ClinicalTrials.gov, FDA, or SEC record.
- Free sample — we'll send the companies in your therapeutic areas
currently showing qualifying public signals. No call, no credit card.
- Weekly feed — only newly identified opportunities, with every supporting
signal and its underlying public evidence.
- Grounded in public evidence — all signals are inferences from public
ClinicalTrials.gov, FDA, and SEC records. They are not claims of financial distress and are
not investment advice.
Built solely from public registry and filing data.
Informational only — not investment advice or a recommendation to transact (see Terms).
Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes.
Get a free preliminary snapshot →Launch offer through July 31: first full site unlock free — one per company.